In order to monitor neurologic events associated with COVID-19, the National Institute of Neurological Disorders and Stroke has launched a centralized database, the COVID-19 Neuro Databank/Biobank (NeuroCOVID).
Experts in neuroinfectious disease, neuroepidemiology, and vaccines discuss the emergent strains of SARS-CoV-2 and how they may impact the level of protection from COVID-19.
Electronic health record data suggests that patients with dementia are at an increased risk for contracting COVID-19 and suffering severe outcomes.
See More Videos
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.
